Table: Chiome Bioscience - Q1 parent results
May 14 (Reuters)-
Chiome Bioscience Inc.
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
3 months ended 3 months ended Year to
Mar 31, 2026 Mar 31, 2025 Dec 31, 2026
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 147 mln 138 mln
(+6.1 pct) (+7.0 pct)
Operating loss 232 mln loss 264 mln
Recurring loss 232 mln loss 265 mln
Net loss 233 mln loss 266 mln
EPS loss 3.31 yen loss 3.94 yen
Ann Div NIL NIL
-Q2 div NIL NIL
-Q4 div NIL NIL
NOTE - Chiome Bioscience Inc..
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4583.T